3.5. Clinical outcomes
Overall, the cure rates were
87.25% (89 of 102) in the KTP group and 75.98% (389 of 512) in the
CO2 group (Table 3). The cure rates were significantly
different between the two groups (p= 0.0127). In addition, the
recurrence rates were 9.80% (10 of 102) in the KTP group and 10% (34
of 340) in the CO2 group. There was no significant
difference between the recurrence rates of the CO2 group
and the KTP group. Other clinical outcomes, such as death rate,
remission rate, clearance rate, effective rate, and HPV-detected rate,
cannot be compared between the two groups in this study due to those
parameters were rare reported in both groups.